• Search
  • Helpdesk
  • Sales contact
Get your demo
eConsent

From paper consent to patient-friendly consent. Simply.

Clinical trial participants tend to understand only a fraction of the information presented on consent forms. Our AI-powered eConsent solution, embedded into our eCOA platform, instantly transforms traditional consent forms into a multimedia guided experience.
Participants have a better grasp of study procedures, risks, benefits, and commitments prior to giving consent.
Sites benefit from a unified intuitive experience for managing consent, from initial enrollment through to re-consent, without disrupting existing sponsor workflows.

Get your demo
  • PDF to eConsent instantlyRapid conversion of PDF consent forms into multimedia eConsent, thanks to our AI builder, reducing trial setup time
  • No additional systemsEmbedded into our eCOA solution, integrates seamlessly into existing workflows
  • Truly informed participantsA guided, interactive experience so participants can truly understand what they’re signing up for

Kayentis’ eConsent enables the rapid transformation of existing consent forms into an engaging digital experience.
By instantaneously transforming conventional PDF consent forms into dynamic eConsent formats, our AI-powered configuration tool automates content extraction, significantly reducing setup time for sponsors and sites.

Sergio Caldarelli,
eConsent Product Manager at Kayentis

Accelerate the transition from paper-based consent into a multimedia, user-friendly experience

Our AI-powered eConsent solution instantly transforms traditional consent forms into a multimedia guided experience

  • Can be deployed across any study type or therapeutic area, on a global scale
  • Integrates easily with any IRT systems (Interactive Response Technology) to connect solutions and simplify the end-to-end process
  • Meets requirements for secure electronic records and signatures (21 CFR Part 11 compliant)
  • Simplifies the creation of re-consent materials, adaptations and translations that align with regional regulatory requirements
Read the press release

Make consent clearer, simpler, and more engaging for patients

Support informed participation, whether at home or on site, by enabling patients to:

  • Watch short videos
  • Explore unfamiliar terms through an interactive glossary
  • Follow highlighted key information during consent discussions
  • Test their understanding with comprehension questions
  • Personalize the experience with accessibility settings on the device of their choice
Ask for a demo

Reduce site burden and improve your trial efficiency

Sites benefit from a unified intuitive experience for managing consent, from initial enrollment through to re-consent.

  • No additional systems to manage: eConsent is fully embedded into our eCOA platform
  • Easier digital adoption: our eConsent solution integrates seamlessly into existing workflows
  • One unified platform from consent to data collection, with the same credentials
Ask for a demo

You may also like

See all resources

Kayentis launches interactive eConsent solution to simplify and improve patient understanding of clinical trials

eConsent
Kayentis’ AI-enabled eConsent solution turns complex 30- to 50-page consent forms into simplified, multimedia guided experience, while reducing operational…

Engage patients throughout the clinical trial journey

Patient engagement
Want to engage patients throughout the clinical trial journey? Boost retention and drive compliance with patient engagement modules seamlessly…

Empowering patients through education – A structured approach to clinical trial engagement

Patient engagement
Explores a framework for patient education in clinical trials, and discover the resulting scientific and operational benefits….
Kayentis launches interactive eConsent solution to simplify and improve patient understanding of clinical trials
Kayentis’ AI-enabled eConsent solution turns complex 30- to 50-page consent forms into simplified, multimedia guided experience, while reducing operational burden for sites and sponsors
  • Read the full press release